Florian Reinaud

Director/Board Member at SENSORION

53 year

Health Technology

Finance

Consumer Services

Profile

Florian Nicolas Christian Reinaud is the founder of Concilio.
Dr. Reinaud is currently Director at Sensorion SA, Director at Sensome SAS since 2017, and Non-Executive Director at Scancell Holdings Plc since 2024.
Former roles include Director at Kuros Biosurgery Holding AG, Director at Zealand Pharma A from 2010 to 2012, Director at Praxim SA, Director at Voluntis SA, Director at OMNI Orthopaedics, Inc., Director at FAB Pharma SAS, Director at Hansa Biopharma AB from 2024 to 2025, Investment Manager at Altaroc Partners SA in 2008, Analyst at Schroder Salomon Smith Barney, General Partner at Innovation Capital SASU from 2014 to 2015, Chief Financial Officer at DBV Technologies SA, and Analyst at Schroder Salomon Smith Barney International Ltd. in 2003.
Education includes undergraduate studies at the University of Oxford and a doctorate from Imperial College London.

Florian Reinaud active positions

Companies	Position	Start
SENSORION	Director/Board Member	-
SCANCELL HOLDINGS PLC	Director/Board Member	09/07/2024
Sensome SAS Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Develops remote monitoring invasive vascular medical devices	Director/Board Member	31/05/2017

All active positions of Florian Reinaud

Former positions of Florian Reinaud

Companies	Position	End
HANSA BIOPHARMA AB	Director/Board Member	01/09/2025
Innovation Capital SASU Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation.	Private Equity Investor	29/07/2015
Altaroc Partners SA Altaroc Partners SA Investment ManagersFinance Altaroc Partners invests in companies located across the globe primarily in Europe and North America. The firm focuses on technology, healthcare, b2b services and digital consumer sectors. It provides financing for LBO and buyout transactions. It also makes co-investments.	Private Equity Investor	31/12/2007
Schroder Salomon Smith Barney International Ltd. Schroder Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	18/05/2003
FAB Pharma SAS FAB Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops drugs for the treatments of bacterial infections	Director/Board Member	-

See the detail of Florian Reinaud's experience

Training of Florian Reinaud

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Florian Reinaud's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
University of Oxford University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Altaroc Partners SA Altaroc Partners SA Investment ManagersFinance Altaroc Partners invests in companies located across the globe primarily in Europe and North America. The firm focuses on technology, healthcare, b2b services and digital consumer sectors. It provides financing for LBO and buyout transactions. It also makes co-investments.	Finance
Schroder Salomon Smith Barney Schroder Salomon Smith Barney Investment Banks/BrokersFinance Provides securities brokerage services	Finance
Kuros Biosurgery Holding AG Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs for biosurgery, tissue repair and regeneration	Commercial Services
Innovation Capital SASU Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation.	Finance
Zealand Pharma A/S Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines	Health Technology
DBV Technologies SA DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy	Health Technology
Praxim SA Praxim SA Medical SpecialtiesHealth Technology Develops and commercializes surgical robots, manual instruments & related software solutions	Health Technology
Schroder Salomon Smith Barney International Ltd. Schroder Salomon Smith Barney International Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
Hansa Biopharma AB Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory	Health Technology
Voluntis SA Voluntis SA Packaged SoftwareTechnology Services Develops anti-cancer treatment platform	Technology Services
Scancell Holdings Plc Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines	Health Technology
OMNI Orthopaedics, Inc. OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and distributes orthopedic implants	Health Technology
FAB Pharma SAS FAB Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops drugs for the treatments of bacterial infections	Commercial Services
Sensorion SA Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders	Health Technology
Concilio
Sensome SAS Sensome SAS Electronic Equipment/InstrumentsElectronic Technology Develops remote monitoring invasive vascular medical devices	Electronic Technology